
from
EIU Country Analysis253 word report
published Jul 03, 2009
Price
$34.00 available for immediate download
Report Overview
Search Inside
About
EIU Country Analysis
FROM DIALOG NEWSEDGE [Nikkei English News (Japan)] Eisai Co. (####.TO) said Friday the U.S. Food and Drug Administration didn't approve pediatric exclusivity status for its best-selling drug, Aricept, eliminating the possibility of a...
|
| Source: | Healthcare Industry Briefing
|
| Geography / Regions: | Japan
|
| Industry: | Healthcare, Pharma & biotech
|
| Free Sample: |
Click Here to Download
|
| Format: | | HTML |  |
|
The Economist Intelligence Unit, a division of London's Economist Group, is the most respected provider of country analysis for governments, multi-national corporations and financial institutions around the world. Through our network of over 500 international contributor economists, we establish independent macro-economic outlooks and detailed reports on the political and commercial environments for over 200 countries around the world.